New York City, NY -- (SBWIRE) -- 01/10/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Receptos Inc (NASDAQ:RCPT), XOMA Corp (NASDAQ:XOMA), Material Sciences Corporation (NASDAQ:MASC), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)
Receptos Inc (NASDAQ:RCPT) gained 12.59%, trading on 2.60 million shares, to end the trade at $35.50. The stock changed hands in a range of $32.00 to $36.15, bringing its market capitalization to about $650.99 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $13.00 and was moved to the maximum level of $36.15. Receptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company’s product candidates span three specialty disease areas. The Company’s lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD).
What was the Moving Force behind RPCT on Bullish Run? Read This Research Report
XOMA Corp (NASDAQ:XOMA) added 14.11%, to complete the trading session at $8.17, with a total volume of 4.39 million shares. The stock, on average, trades on a volume of 2.58 million shares. It floated in a range of $7.29 to $8.18 during the last trading session, with a beta value of 2.41. Its market capitalization now moved to about $846.63 million. In the past 52 weeks, the share price has not declined below $2.46 and above $8.18. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
For How Long XOMA will fight for Profitability? Read This Trend Analysis report
Material Sciences Corporation (NASDAQ:MASC) recorded a gain of13.46% and was in a range of $12.71-$12.85 before closing at $12.73. The stock completed the day with a total volume of 3.04 million shares, versus an average volume of 30,098 shares. The share price hit its 52-week low of $8.60 and $12.85 was the best price. Material Sciences Corporation (MSC) and its subsidiaries design, manufacture and market material-based solutions for acoustical and coated applications. The Company operates three manufacturing plants in the United States and Europe: one facility in Elk Grove Village, Illinois (Elk Grove Village); one facility in Walbridge, Ohio (Walbridge); and one facility in Eisenach, Germany (Eisenach).
For How Long MASC Gloss will Attract Investors? Find out via this report
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) added 13.25% yesterday, bringing its market capitalization around $102.70 million. The share price, after opening at $0.66, made a high of $0.76 and hovered above $0.64 to end the day at $0.700. The total number of shares that changed hands during the session was 20.76 million shares, as compared to average trading volume of 2.16 million shares. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials.
Will RNN Continue To Move Higher? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)